Back
Genmab AS Vs. Ascendis Pharma AS Industry Stock Comparison
Sell
25
GMAB
Genmab AS
Last Price:
20.65
Seasonality Move:
5.02%
Sell
27
ASND
Ascendis Pharma AS
Last Price:
130.01
Seasonality Move:
20.86%
Sell
25
Genmab AS (GMAB)
is a Sell
Is Genmab AS a Buy, Sell or Hold?
- The current Genmab AS [GMAB] share price is $20.65. The Score for GMAB is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- GMAB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Ascendis Pharma AS (ASND)
is a Sell
Is Ascendis Pharma AS a Buy, Sell or Hold?
- The current Ascendis Pharma AS [ASND] share price is $129.81. The Score for ASND is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- ASND is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ASND Stock Price Chart
What is Ascendis Pharma AS's stock price today?
-
The Ascendis Pharma AS share price today is $129.81
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ASND is experiencing buying pressure, which is a positive indicator for future bullish movement.
GMAB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.81 | Sell |
| Relative Strength Index (14 RSI): | 29.23 | Sell |
| Chaikin Money Flow: | -593518 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.15 - 23.15) | Sell |
| Bollinger Bands (100): | (22.84 - 27.52) | Sell |
ASND Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.53 | Sell |
| Relative Strength Index (14 RSI): | 53.83 | Buy |
| Chaikin Money Flow: | 334016 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (124.01 - 129.03) | Buy |
| Bollinger Bands (100): | (124.29 - 141.45) | Sell |
GMAB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.77 | Sell |
| 20-day SMA: | 21.98 | Sell |
| 50-day SMA: | 23.16 | Sell |
| 200-day SMA: | 26.87 | Sell |
| 8-day EMA: | 20.93 | Sell |
| 20-day EMA: | 21.74 | Sell |
| 50-day EMA: | 23.1 | Sell |
| 200-day EMA: | 26.68 | Sell |
ASND Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 125.01 | Buy |
| 20-day SMA: | 125.87 | Buy |
| 50-day SMA: | 133.06 | Sell |
| 200-day SMA: | 136.78 | Sell |
| 8-day EMA: | 125.66 | Buy |
| 20-day EMA: | 126.61 | Buy |
| 50-day EMA: | 129.57 | Buy |
| 200-day EMA: | 130.24 | Sell |
Genmab AS Earnings Growth & GMAB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.16 per share, and an increase next year of $0.28 per share.
Ascendis Pharma AS Earnings Growth & ASND Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.63 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.89 per share, and an increase next year of $4.01 per share.
Genmab AS Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ascendis Pharma AS Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||